These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37010458)

  • 1. The Volumetric Effect of Botulinum Toxin Type A Injection on the Parotid Gland: A Randomized Controlled Trial.
    Jeong WS; Hong DW; Ahn TJ; Han HH
    Plast Reconstr Surg; 2024 Feb; 153(2):337-343. PubMed ID: 37010458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of botulinum toxin type A injection into human masseter muscle on stimulated parotid saliva flow rate.
    Kwon JS; Kim ST; Jeon YM; Choi JH
    Int J Oral Maxillofac Surg; 2009 Apr; 38(4):316-20. PubMed ID: 19231136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botox facial slimming/facial sculpting: the role of botulinum toxin-A in the treatment of hypertrophic masseteric muscle and parotid enlargement to narrow the lower facial width.
    Wu WT
    Facial Plast Surg Clin North Am; 2010 Feb; 18(1):133-40. PubMed ID: 20206096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Benign Parotid Hypertrophy: A Prospective Study.
    Chen Z; Chen Z; Liu W; Wei Z; Pang R; Cheng X; Wang S; Chen S; Liu L; Li G
    Plast Reconstr Surg; 2022 Nov; 150(5):979e-986e. PubMed ID: 35994355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The mechanism of inhibitory effect on parotid gland secretion with local injection of botulinum toxin type A in the rat].
    Wen WD; Yuan F; Hou YP
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Jan; 44(1):38-40. PubMed ID: 19489258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of High-Dose Botulinum Toxin Injections for Parotid and Submandibular Gland Radioprotection.
    Mueller J; Langbein T; Mishra A; Baum RP
    Toxins (Basel); 2022 Jan; 14(1):. PubMed ID: 35051042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RimabotulinumtoxinB versus OnabotulinumtoxinA in the treatment of masseter hypertrophy: a 24-week double-blind randomized split-face study.
    Lee DH; Jin SP; Cho S; Feneran A; Youn CS; Won CH; Park GH; Kim BW; An J; Chang SE; Lee MW
    Dermatology; 2013; 226(3):227-32. PubMed ID: 23774030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin injections for children with excessive drooling.
    Hassin-Baer S; Scheuer E; Buchman AS; Jacobson I; Ben-Zeev B
    J Child Neurol; 2005 Feb; 20(2):120-3. PubMed ID: 15794177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin type A treatment for contouring of the lower face.
    Park MY; Ahn KY; Jung DS
    Dermatol Surg; 2003 May; 29(5):477-83; discussion 483. PubMed ID: 12752514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of botulinum toxin A for treatment of drooling.
    Lipp A; Trottenberg T; Schink T; Kupsch A; Arnold G
    Neurology; 2003 Nov; 61(9):1279-81. PubMed ID: 14610139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of botulinum toxin injection in reducing deltoid muscle hypertrophy.
    Shin SH; Park SJ; Yeoum SH; Youn CS; Park KY
    Dermatol Ther; 2021 Nov; 34(6):e15168. PubMed ID: 34676643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
    Banerjee KJ; Glasson C; O'Flaherty SJ
    Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum Toxin Injection for Chronic Parotitis: A Multi-Center and Prospective Trial.
    Kwon SY; Chun KJ; Kil HK; Oh KH; Kim C; Jang SJ; Kim MS
    Laryngoscope; 2021 Jun; 131(6):E1903-E1909. PubMed ID: 33111982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type B: pH change reduces injection pain, retains efficacy.
    Lowe PL; Lowe NJ
    Dermatol Surg; 2014 Dec; 40(12):1328-33. PubMed ID: 25350125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Pilot Study on the Treatment of Posterior Cheek Enlargement in HIV+ Patients With Botulinum Toxin A.
    Scali C; Carruthers A; Malpas D; Humphrey S
    Dermatol Surg; 2015 Nov; 41(11):1300-8. PubMed ID: 26469200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Botulinum Toxin Injection on Bruxism: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Chen Y; Tsai CH; Bae TH; Huang CY; Chen C; Kang YN; Chiu WK
    Aesthetic Plast Surg; 2023 Apr; 47(2):775-790. PubMed ID: 36694050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of masseter hypertrophy for tailored botulinum toxin type A treatment.
    Xie Y; Zhou J; Li H; Cheng C; Herrler T; Li Q
    Plast Reconstr Surg; 2014 Aug; 134(2):209e-218e. PubMed ID: 25068343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is it always necessary to apply botulinum toxin into the lower facial muscles in hemifacial spasm?: a randomized, single-blind, crossover trial.
    Colakoglu BD; Cakmur R; Uzunel F
    Eur Neurol; 2011; 65(5):286-90. PubMed ID: 21502764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy.
    Gonzalez-L MD; Martinez C; Bori Y Fortuny I; Suso-Vergara S
    Am J Phys Med Rehabil; 2017 Feb; 96(2):68-76. PubMed ID: 28099276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change of distribution and timing of bite force after botulinum toxin type A injection evaluated by a computerized occlusion analysis system.
    Song JH; Cho ES; Kim ST; Ahn HJ
    Yonsei Med J; 2014 Jul; 55(4):1123-9. PubMed ID: 24954346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.